Patents by Inventor Gary E. Rehm

Gary E. Rehm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090316140
    Abstract: A method and apparatus for using an infrared reading to detect the misidentification of a diagnostic test strip disposed on a feed table comprising the steps of determining if the test strip possesses specified reagents, reading the infrared reflectances from the reagent positions, determining if the reflectances are within an acceptable predetermined range and aborting the test if the infrared reflectances are not within the acceptable predetermined range.
    Type: Application
    Filed: September 1, 2009
    Publication date: December 24, 2009
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventor: Gary E. Rehm
  • Patent number: 7601544
    Abstract: A method and apparatus for using an infrared reading to detect the misidentification of a diagnostic test strip disposed on a feed table comprising the steps of determining if the test strip possesses specified reagents, reading the infrared reflectances from the reagent positions, determining if the reflectances are within an acceptable predetermined range and aborting the test if the infrared reflectances are not within the acceptable predetermined range.
    Type: Grant
    Filed: January 28, 2002
    Date of Patent: October 13, 2009
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventor: Gary E. Rehm
  • Patent number: 7001737
    Abstract: Disclosed is an assay for determining the presence and concentration of trypsin inhibitor in urine samples. The assay reagents, which may be used either in the liquid or dry states, include trypsin, a trypsin substrate and a polycarboxylic chelating agent. The inclusion of the chelating agent in the assay has been found to reduce variation in the assay results.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: February 21, 2006
    Assignee: Bayer Corporation
    Inventors: Gary E. Rehm, Michael J. Pugia, Paul F. Corey
  • Patent number: 6955921
    Abstract: A compound of the formula (I) wherein R1 is a protecting group for N?, R2 is a protecting group for NG, and R3 is aryl, and wherein the compound of formula (I) is a trypsin substrate such that trypsin cleaves the O—C single bond, which liberates R3—OH; a diagnostic device comprising same; a method for preparing the diagnostic device; and a method of using the diagnostic device to detect levels of urinary trypsin inhibitor in a biological sample; and a diagnostic kit for detecting levels of urinary trypsin inhibitor in a biological sample.
    Type: Grant
    Filed: November 4, 2002
    Date of Patent: October 18, 2005
    Assignee: Bayer Corporation
    Inventors: Paul F. Corey, Steven W. Felman, Gary E. Rehm, Michael J. Pugia
  • Patent number: 6770764
    Abstract: A compound of the formula (I) wherein R1 is a protecting group for N&agr;, R2 is a protecting group for NG, and R3 is aryl, and wherein the compound of formula (I) is a trypsin substrate such that trypsin cleaves the O—C single bond, which liberates R3—OH; a diagnostic device comprising same; a method for preparing the diagnostic device; and a method of using the diagnostic device to detect levels of urinary trypsin inhibitor in a biological sample; and a diagnostic kit for detecting levels of urinary trypsin inhibitor in a biological sample.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: August 3, 2004
    Assignee: Bayer Corporation
    Inventors: Paul F. Corey, Steven W. Felman, Gary E. Rehm, Michael J. Pugia
  • Publication number: 20030125577
    Abstract: A compound of the formula (I) 1
    Type: Application
    Filed: November 4, 2002
    Publication date: July 3, 2003
    Inventors: Paul F. Corey, Steven W. Felman, Gary E. Rehm, Michael J. Pugia
  • Publication number: 20020132363
    Abstract: A method and apparatus for using an infrared reading to detect the misidentification of a diagnostic test strip disposed on a feed table comprising the steps of determining if the test strip possesses specified reagents, reading the infrared reflectances from the reagent positions, determining if the reflectances are within an acceptable predetermined range and aborting the test if the infrared reflectances are not within the acceptable predetermined range.
    Type: Application
    Filed: January 28, 2002
    Publication date: September 19, 2002
    Inventor: Gary E. Rehm
  • Publication number: 20020004219
    Abstract: A compound of the formula (I) 1
    Type: Application
    Filed: April 30, 2001
    Publication date: January 10, 2002
    Inventors: Paul F. Corey, Steven W. Felman, Gary E. Rehm, Michael J. Pugia
  • Publication number: 20010055816
    Abstract: Disclosed is an assay for determining the presence and concentration of trypsin inhibitor in urine samples. The assay reagents, which may be used either in the liquid or dry states, include trypsin, a trypsin substrate and a polycarboxylic chelating agent. The inclusion of the chelating agent in the assay has been found to reduce variation in the assay results.
    Type: Application
    Filed: April 30, 2001
    Publication date: December 27, 2001
    Inventors: Gary E. Rehm, Michael J. Pugia, Paul F. Corey
  • Patent number: 6316264
    Abstract: An improved test strip for determining the presence or concentration of unknown or a constituent in a liquid test sample is disclosed. The test strip comprises a support strip and a test pad, wherein the test pad includes a carrier matrix incorporating a reagent composition capable of interacting with the constituent of interest to produce a detectable or measurable response. The test strip further comprises an infrared dye, applied either to the support strip or incorporated into a test pad, which ensures proper alignment of the test strip in an apparatus having a detection system for the detectable or measurable response. The improved test strip reduces the number of erroneous assays for the constituent of interest.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: November 13, 2001
    Assignee: Bayer Corporation
    Inventors: Paul F. Corey, Michael J. Pugia, Gary E. Rehm
  • Patent number: 6261522
    Abstract: An apparatus for automatically detecting the presence of a reagent strip (14) having a body fluid sample disposed thereon and for inspecting the reagent strip (14) after the presence of the reagent strip (14) is detected is provided with a detection system adapted to automatically detect the presence of a reagent strip (14) at a reagent strip receiving area (12), a light source (64 or 68) adapted to illuminate the reagent strip (14) after the presence of the reagent strip (14) at the reagent strip receiving area (12) is detected, and a detector (66 or 70) adapted to receive light from the reagent strip (14) when the reagent strip (14) is being illuminated by the light source.
    Type: Grant
    Filed: October 13, 1998
    Date of Patent: July 17, 2001
    Assignee: Bayer Corporation
    Inventors: David Hough, Willis E. Howard, III, Richard Hurtle, Gary E. Rehm
  • Patent number: 6183694
    Abstract: An apparatus adapted to inspect reagent strips having fluid samples, such as urine samples, disposed thereon and to reduce the likelihood of contamination of one of the fluid samples with another of the fluid samples is provided with a reagent strip support (22) adapted to support a reagent strip (14) having a plurality of reagent pads (26) disposed in a longitudinal direction along the reagent strip (26), including reagent pad which has a reagent sensitive to contamination.
    Type: Grant
    Filed: October 30, 1998
    Date of Patent: February 6, 2001
    Assignee: Bayer Corporation
    Inventors: Marilyn Radtke, Gary E. Rehm
  • Patent number: 6180409
    Abstract: An apparatus for inspecting a reagent strip (14) having a fluid sample disposed thereon is provided with a conveyor system (80) adapted to move the reagent strip (14) from a first reagent strip inspection location to a second reagent strip inspection location, a first readhead (60) associated with the first reagent strip inspection location, and a second readhead (62) associated with the second reagent strip inspection location. Each of the readheads (60, 62) has a light source (64, 68) and a light detector (66, 70) associated therewith, each light source (64, 68) being adapted to illuminate the reagent strip (14) at one of the reagent strip inspection locations and each light detector (66, 70) being adapted to detect light from the reagent strip (14) when the reagent strip (14) is disposed at one of the reagent strip inspection locations.
    Type: Grant
    Filed: October 13, 1998
    Date of Patent: January 30, 2001
    Assignee: Bayer Corporation
    Inventors: Willis E. Howard, III, Gary E. Rehm, Gerald H. Shaffer
  • Patent number: 5724148
    Abstract: An apparatus for analyzing a body-fluid sample, such as a urine sample, disposed on a reagent pad is provided with means for illuminating the reagent pad on which the body-fluid sample is disposed, means for detecting light received from the reagent pad and generating a first reflectance signal at a first time and a second reflectance signal at a second time, and means for assigning a color to the body-fluid sample based upon the magnitudes of the first and second reflectance signals. The means for assigning the color to the body-fluid sample may include means for determining a pair of color coefficients each of which has a magnitude based upon the magnitudes of the reflectance signals and means for assigning the color to the body-fluid sample based upon the magnitudes of the color coefficients.
    Type: Grant
    Filed: May 9, 1996
    Date of Patent: March 3, 1998
    Assignee: Bayer Corporation
    Inventors: Willis Howard, III, Gary E. Rehm
  • Patent number: 5654803
    Abstract: An apparatus for analyzing a body-fluid sample disposed on a reagent pad is provided with a light bulb for successively illuminating a plurality of different portions of the reagent pad on which the body-fluid sample is disposed and a detector array for detecting light received from the reagent pad and generating a plurality of reflectance signals in response to light received from a corresponding one of the different portions of the reagent pad. The apparatus is also provided with means for determining whether the magnitude of one of the reflectance signals is substantially different than the magnitude of another of the reflectance signals. Where the body-fluid sample is urine, this capability allows the apparatus to detect the presence of non-hemolyzed in the urine sample. The light bulb may successively illuminate a plurality of overlapping portions of the reagent pad, and may successively illuminate at least three different portions of the reagent pad which are linearly offset from each other.
    Type: Grant
    Filed: May 9, 1996
    Date of Patent: August 5, 1997
    Assignee: Bayer Corporation
    Inventors: Willis E. Howard, III, Marilyn Radtke, Gary E. Rehm